Interferon-αPulmonary arterial hypertension: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1613卷 / 1期

关键词：

D O I：

10.1007/s40278-016-20117-5

中图分类号：

学科分类号：

摘要：

引用

页码：160 / 160

共 50 条

[31] Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
Anthi, Anastasia
Stagaki, Eleni
Rallidis, Loukianos
Konstantonis, Dimitrios
Evangelopoulos, Maria-Eleftheria
Voumvourakis, Konstantinos
Armaganidis, Apostolos
Orfanos, Stylianos E.
ERJ OPEN RESEARCH, 2020, 6 (01)
[32] Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report
Ledinek, A. H.
Jazbec, S. S.
Drinovec, I.
Rot, U.
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (07) : 885 - 886
[33] Pulmonary Arterial Hypertension (pah) Associated With Interferon β1b: a Case Report
Papani, R.
Duarte, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[34] DasatinibFirst report of pulmonary arterial hypertension: case report
Reactions Weekly, 2009, 1253 (1) : 13 - 13
[35] DasatinibSevere pulmonary arterial hypertension: case report
Reactions Weekly, 2025, 2054 (1) : 142 - 142
[36] PhenylpropanolamineSevere pulmonary arterial hypertension: case report
Reactions Weekly, 2021, 1862 (1) : 409 - 409
[37] TeriflunomideIdiopathic pulmonary arterial hypertension : case report
Reactions Weekly, 2024, 2019 (1) : 427 - 427
[38] AbataceptWorsening of pulmonary arterial hypertension: case report
Reactions Weekly, 2019, 1775 (1) : 13 - 13
[39] BortezomibAcute pulmonary arterial hypertension: case report
Reactions Weekly, 2022, 1929 (1) : 149 - 149
[40] DasatinibReversible pulmonary arterial hypertension: case report
Reactions Weekly, 2022, 1930 (1) : 220 - 220

← 1 2 3 4 5 →